Major considerations in vaccinating children in Africa against COVID-19

Africa has about 41% of its population below the age of 15. The continent also comprises mostly low and middle income countries. As the developed countries worldwide begin to vaccinate children against COVID-19, we highlight the prerequisites, necessities and consequences of vaccinating or failing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Osakuade, Oluwanifemi Williams, Anyam, Ngusha Victory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352650/
https://www.ncbi.nlm.nih.gov/pubmed/35945971
http://dx.doi.org/10.1016/j.jvacx.2022.100199
_version_ 1784762694779273216
author Osakuade, Oluwanifemi Williams
Anyam, Ngusha Victory
author_facet Osakuade, Oluwanifemi Williams
Anyam, Ngusha Victory
author_sort Osakuade, Oluwanifemi Williams
collection PubMed
description Africa has about 41% of its population below the age of 15. The continent also comprises mostly low and middle income countries. As the developed countries worldwide begin to vaccinate children against COVID-19, we highlight the prerequisites, necessities and consequences of vaccinating or failing to vaccinate children in Africa.
format Online
Article
Text
id pubmed-9352650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93526502022-08-05 Major considerations in vaccinating children in Africa against COVID-19 Osakuade, Oluwanifemi Williams Anyam, Ngusha Victory Vaccine X Review Africa has about 41% of its population below the age of 15. The continent also comprises mostly low and middle income countries. As the developed countries worldwide begin to vaccinate children against COVID-19, we highlight the prerequisites, necessities and consequences of vaccinating or failing to vaccinate children in Africa. Elsevier 2022-08-05 /pmc/articles/PMC9352650/ /pubmed/35945971 http://dx.doi.org/10.1016/j.jvacx.2022.100199 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Osakuade, Oluwanifemi Williams
Anyam, Ngusha Victory
Major considerations in vaccinating children in Africa against COVID-19
title Major considerations in vaccinating children in Africa against COVID-19
title_full Major considerations in vaccinating children in Africa against COVID-19
title_fullStr Major considerations in vaccinating children in Africa against COVID-19
title_full_unstemmed Major considerations in vaccinating children in Africa against COVID-19
title_short Major considerations in vaccinating children in Africa against COVID-19
title_sort major considerations in vaccinating children in africa against covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352650/
https://www.ncbi.nlm.nih.gov/pubmed/35945971
http://dx.doi.org/10.1016/j.jvacx.2022.100199
work_keys_str_mv AT osakuadeoluwanifemiwilliams majorconsiderationsinvaccinatingchildreninafricaagainstcovid19
AT anyamngushavictory majorconsiderationsinvaccinatingchildreninafricaagainstcovid19

Ejemplares similares